164 related articles for article (PubMed ID: 35781099)
1. Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies.
Lee SJ; Cutler C; Blazar BR; Tu A; Yang Z; Pavletic SZ
Transplant Cell Ther; 2022 Oct; 28(10):700.e1-700.e6. PubMed ID: 35781099
[TBL] [Abstract][Full Text] [Related]
2. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Cutler C; Lee SJ; Arai S; Rotta M; Zoghi B; Lazaryan A; Ramakrishnan A; DeFilipp Z; Salhotra A; Chai-Ho W; Mehta R; Wang T; Arora M; Pusic I; Saad A; Shah NN; Abhyankar S; Bachier C; Galvin J; Im A; Langston A; Liesveld J; Juckett M; Logan A; Schachter L; Alavi A; Howard D; Waksal HW; Ryan J; Eiznhamer D; Aggarwal SK; Ieyoub J; Schueller O; Green L; Yang Z; Krenz H; Jagasia M; Blazar BR; Pavletic S
Blood; 2021 Dec; 138(22):2278-2289. PubMed ID: 34265047
[TBL] [Abstract][Full Text] [Related]
3. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials.
DeFilipp Z; Kim HT; Yang Z; Noonan J; Blazar BR; Lee SJ; Pavletic SZ; Cutler C
Blood Adv; 2022 Dec; 6(24):6263-6270. PubMed ID: 36083121
[TBL] [Abstract][Full Text] [Related]
4. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
[TBL] [Abstract][Full Text] [Related]
5. Belumosudil for chronic graft-versus-host disease.
Taylor B; Cohen J; Tejeda J; Wang TP
Drugs Today (Barc); 2022 May; 58(5):203-212. PubMed ID: 35535812
[TBL] [Abstract][Full Text] [Related]
6. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
Lee SJ; Wolff D; Kitko C; Koreth J; Inamoto Y; Jagasia M; Pidala J; Olivieri A; Martin PJ; Przepiorka D; Pusic I; Dignan F; Mitchell SA; Lawitschka A; Jacobsohn D; Hall AM; Flowers ME; Schultz KR; Vogelsang G; Pavletic S
Biol Blood Marrow Transplant; 2015 Jun; 21(6):984-99. PubMed ID: 25796139
[TBL] [Abstract][Full Text] [Related]
7. ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease.
Jagasia M; Lazaryan A; Bachier CR; Salhotra A; Weisdorf DJ; Zoghi B; Essell J; Green L; Schueller O; Patel J; Zanin-Zhorov A; Weiss JM; Yang Z; Eiznhamer D; Aggarwal SK; Blazar BR; Lee SJ
J Clin Oncol; 2021 Jun; 39(17):1888-1898. PubMed ID: 33877856
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China.
Wang Y; Wu D; Zhang X; Li Y; He Y; Liu Q; Xuan L; Li Z; Qi K; Sun Y; Wang S; Mo W; Gao L; Hua Y; Wang Y; Zhang Y
BMC Med; 2024 Mar; 22(1):142. PubMed ID: 38532458
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported treatment response in chronic graft-
Im A; Pusic I; Onstad L; Kitko CL; Hamilton BK; Alousi AM; Flowers ME; Sarantopoulos S; Carpenter P; White J; Arai S; El Jurdi N; Chen G; Cutler C; Lee S; Pidala J
Haematologica; 2024 Jan; 109(1):143-150. PubMed ID: 37226713
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
Patel SS; Hong S; Rybicki L; Farlow S; Dabney J; Kalaycio M; Sobecks R; Majhail NS; Hamilton BK
Transplant Cell Ther; 2023 Jul; 29(7):465.e1-465.e7. PubMed ID: 37003415
[TBL] [Abstract][Full Text] [Related]
13. [Evolving treatment strategies for chronic graft-versus-host disease].
Inamoto Y
Rinsho Ketsueki; 2022; 63(5):433-439. PubMed ID: 35662168
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
15. Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease.
Martini DJ; Chen YB; DeFilipp Z
Oncologist; 2022 Aug; 27(8):685-693. PubMed ID: 35443042
[TBL] [Abstract][Full Text] [Related]
16. Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease.
Gonzalez R; Gaskill E; Padilla M; Pidala J; Lazaryan A; Perez L; Khimani F; Faramand R
Transplant Cell Ther; 2023 Sep; 29(9):577.e1-577.e9. PubMed ID: 37355201
[TBL] [Abstract][Full Text] [Related]
17. Validation of measurement scales in ocular graft-versus-host disease.
Inamoto Y; Chai X; Kurland BF; Cutler C; Flowers ME; Palmer JM; Carpenter PA; Heffernan MJ; Jacobsohn D; Jagasia MH; Pidala J; Khera N; Vogelsang GB; Weisdorf D; Martin PJ; Pavletic SZ; Lee SJ;
Ophthalmology; 2012 Mar; 119(3):487-93. PubMed ID: 22153706
[TBL] [Abstract][Full Text] [Related]
18. Kinase Inhibition as Treatment for Acute and Chronic Graft-
Braun LM; Zeiser R
Front Immunol; 2021; 12():760199. PubMed ID: 34868001
[TBL] [Abstract][Full Text] [Related]
19. A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease.
Salhotra A; Sandhu K; O'Hearn J; Ali H; Nakamura R; Modi BG
Expert Rev Clin Immunol; 2023 Mar; 19(3):241-251. PubMed ID: 36440483
[TBL] [Abstract][Full Text] [Related]
20. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
